$IROH
Iron Horse Acquisitions Corp Stock $iroh

$iroh Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000121390024028817 Filed on April 01, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$479.9K	$7.030K	$309.0K
YoY Change		-92.08%	70.73%
Operating Profit	-$479.9K		-$309.0K
YoY Change	359.05%		70.73%
Interest Expense	$858.3K
YoY Change
% of Operating Profit
Other Income/Expense, Net	$1.164M
YoY Change
Pretax Income	$684.5K	-$7.030K	-$309.0K
YoY Change		-92.08%	70.73%
Income Tax	$211.1K	-$230.00	-$230.00
% Of Pretax Income	30.84%
Net Earnings	$473.4K	-$6.810K	-$308.8K
YoY Change	-552.89%	-92.33%	70.6%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	$0.05	$0.00	-$0.03
COMMON SHARES
Basic Shares Outstanding	8.867M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$179.3K	$657.0K	$657.0K
YoY Change
Cash & Equivalents	$179.3K	$657.0K	$657.0K
Short-Term Investments
Other Short-Term Assets	$158.3K	$33.16K	$33.16K
YoY Change		-95.06%	-95.06%
Inventory
Prepaid Expenses		$33.16K
Receivables
Other Receivables	$206.5K
Total Short-Term Assets	$544.2K	$690.1K	$690.1K
YoY Change		2.75%	2.75%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$69.85M
YoY Change
Other Assets		$69.00M	$69.00M
YoY Change
Total Long-Term Assets	$69.85M	$69.00M	$69.00M
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$544.2K	$690.1K	$690.1K
Total Long-Term Assets	$69.85M	$69.00M	$69.00M
Total Assets	$70.40M	$69.69M	$69.69M
YoY Change		10275.65%	10275.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$213.5K	$292.7K	$292.7K
YoY Change		66.07%	66.07%
Deferred Revenue
YoY Change
Short-Term Debt	$557.8K	$557.8K	$557.8K
YoY Change		-16.85%	-16.85%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.097M	$861.6K	$861.6K
YoY Change		1.72%	1.72%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.519M	$2.519M	$2.519M
YoY Change
Total Long-Term Liabilities	$2.519M	$2.519M	$2.519M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.097M	$861.6K	$861.6K
Total Long-Term Liabilities	$2.519M	$2.519M	$2.519M
Total Liabilities	$3.616M	$3.380M	$3.380M
YoY Change		299.05%	299.05%
SHAREHOLDERS EQUITY
Retained Earnings	-$2.814M	-$2.690M
YoY Change		1242.59%
Common Stock	$197.00	$200.00
YoY Change		3.63%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$2.814M	$66.31M	$66.31M
YoY Change
Total Liabilities & Shareholders Equity	$70.40M	$69.69M	$69.69M
YoY Change		10275.65%	10275.65%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$473.4K	-$6.810K	-$308.8K
YoY Change	-552.89%	-92.33%	70.6%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$374.1K	-$83.20K	-$83.20K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$3.340K	-$69.00M	-$69.00M
YoY Change
Cash From Investing Activities	$3.337K	-$69.00M	-$69.00M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$106.9K	69.74M	69.74M
YoY Change
NET CHANGE
Cash From Operating Activities	-$374.1K	-83.20K	-83.20K
Cash From Investing Activities	$3.337K	-69.00M	-69.00M
Cash From Financing Activities	-$106.9K	69.74M	69.74M
Net Change In Cash	-$477.7K	657.0K	657.0K
YoY Change
FREE CASH FLOW
Cash From Operating Activities	-$374.1K	-$83.20K	-$83.20K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity Registrant Name EntityRegistrantName	Iron Horse Acquisitions Corp.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity File Number EntityFileNumber	333-275076
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-1783294
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	P.O. Box 2506
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Toluca Lake
CY2023	dei	Entity Address Country EntityAddressCountry	CA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	91610
CY2023	dei	City Area Code CityAreaCode	(310)
CY2023	dei	Local Phone Number LocalPhoneNumber	290-5383
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	true
CY2023Q2	dei	Entity Public Float EntityPublicFloat	0	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	8867000	shares
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	206
CY2023	dei	Auditor Name AuditorName	MaloneBailey, LLP
CY2023	dei	Auditor Location AuditorLocation	Houston, Texas
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	656977	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	33157	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	690134	usd
CY2022Q4	us-gaap	Deferred Costs DeferredCosts	671667	usd
CY2023Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	69000000	usd
CY2023Q4	us-gaap	Assets Assets	69690134	usd
CY2022Q4	us-gaap	Assets Assets	671667	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	70810	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	70011	usd
CY2023Q4	iroh	Accrued Offering Costs AccruedOfferingCosts	221914	usd
CY2022Q4	iroh	Accrued Offering Costs AccruedOfferingCosts	106250	usd
CY2023Q4	iroh	Overallotment Liability OverallotmentLiability	11135	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	861640	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	847041	usd
CY2023Q4	iroh	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable	2518500	usd
CY2023Q4	us-gaap	Liabilities Liabilities	3380140	usd
CY2022Q4	us-gaap	Liabilities Liabilities	847041	usd
CY2023Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	6900000	shares
CY2023Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	69000000	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1932000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1932000	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	200	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	193	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	24807	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2690206	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-200374	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-2690006	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-175374	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	69690134	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	671667	usd
CY2023	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	309018	usd
CY2022	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	181003	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-309018	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-181003	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-309018	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-181003	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-226	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-308792	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-181003	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	5629	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-181003	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-175374	usd
CY2023	iroh	Stock Issued During Period Value Sale Of Private Placement Warrants StockIssuedDuringPeriodValueSaleOfPrivatePlacementWarrants	2457000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	43470	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Mark To Market AdjustmentsToAdditionalPaidInCapitalMarkToMarket	3283710	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	275665	usd
CY2023	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	4	usd
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	-7714359	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-308792	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-2690006	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-308792	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-181003	usd
CY2023	iroh	Payment Of Office Expenses Made By Sponsor PaymentOfOfficeExpensesMadeBySponsor	-269251	usd
CY2022	iroh	Payment Of Office Expenses Made By Sponsor PaymentOfOfficeExpensesMadeBySponsor	-113601	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	-11301	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	33157	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	799	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	67402	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-83200	usd
CY2023	iroh	Payments For Investment Of Cash Into Trust Account PaymentsForInvestmentOfCashIntoTrustAccount	69000000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-69000000	usd
CY2023	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	68413500	usd
CY2023	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	2457000	usd
CY2023	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-1014523	usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	115800	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	69740177	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	656977	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	656977	usd
CY2023	iroh	Remeasurement Of Common Stock Subject To Possible Redemption RemeasurementOfCommonStockSubjectToPossibleRedemption	7714359	usd
CY2023Q4	iroh	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable	2518500	usd
CY2023	iroh	Issuance Of Representative Shares IssuanceOfRepresentativeShares	4	usd
CY2023	iroh	Issuance Of Founder Shares IssuanceOfFounderShares	3	usd
CY2023	iroh	Offering Costs Included In Accrued Offering Costs OfferingCostsIncludedInAccruedOfferingCosts	221914	usd
CY2022	iroh	Offering Costs Included In Accrued Offering Costs OfferingCostsIncludedInAccruedOfferingCosts	106250	usd
CY2023	us-gaap	Notes Issued1 NotesIssued1	632273	usd
CY2022	us-gaap	Notes Issued1 NotesIssued1	507986	usd
CY2023Q4	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	69000000	usd
CY2023	iroh	Transaction Costs Amount TransactionCostsAmount	4651705	usd
CY2023	iroh	Cash Underwriting Fees CashUnderwritingFees	586500	usd
CY2023Q4	iroh	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable	2518500	usd
CY2023	iroh	Sale Of Stock Other Offering Costs SaleOfStockOtherOfferingCosts	1546705	usd
CY2023	iroh	Condition For Future Business Combination Use Of Proceeds Percentage ConditionForFutureBusinessCombinationUseOfProceedsPercentage	0.80	pure
CY2023Q4	iroh	Payments For Investment Of Cash In Trust Account PaymentsForInvestmentOfCashInTrustAccount	229770	usd
CY2023Q4	iroh	Payments For Investment Of Cash In Underwriters PaymentsForInvestmentOfCashInUnderwriters	233600	usd
CY2023Q4	iroh	Sale Of Stock Exercise Price Per Share SaleOfStockExercisePricePerShare	0.0333
CY2023Q4	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	459540	usd
CY2023Q4	iroh	Percentage Of Outstanding Public Shares PercentageOfOutstandingPublicShares	1	pure
CY2023Q4	iroh	Interest Of Liquidation Expenses InterestOfLiquidationExpenses	100000	usd
CY2023Q4	us-gaap	Cash Cash	656977	usd
CY2023	iroh	Working Capital Deficit WorkingCapitalDeficit	171506	usd
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.001	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.003	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">The preparation of the financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p>
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	656977	usd
CY2023Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	69000000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	82463	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	17795	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023	iroh	Restriction Period For Transfer Assignment Or Sales RestrictionPeriodForTransferAssignmentOrSales	P30Y
CY2023Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.01
CY2023	iroh	Prior Written Notice PriorWrittenNotice	P30D
CY2023Q4	us-gaap	Share Price SharePrice	18
CY2023	iroh	Period After Closing Of Initial Business Combination To File Resale Shelf Registration Statement PeriodAfterClosingOfInitialBusinessCombinationToFileResaleShelfRegistrationStatement	45
CY2023	iroh	Percentage Of Underwriting Discount PercentageOfUnderwritingDiscount	0.0085	pure
CY2023	iroh	Cash Underwriting Fees CashUnderwritingFees	586500	usd
CY2023	iroh	Percentage Of Deferred Underwriting Discount PercentageOfDeferredUnderwritingDiscount	0.0365	pure
CY2021Q4	iroh	Percentage Of Holding Of Shares After Initial Public Offering PercentageOfHoldingOfSharesAfterInitialPublicOffering	0.22	pure
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	6900000	shares
CY2023	iroh	Number Of Shares Subject To Forfeiture NumberOfSharesSubjectToForfeiture	32200	shares
CY2023	iroh	Percentage Of Issued And Outstanding PercentageOfIssuedAndOutstanding	0.22	pure
CY2023	iroh	Period Ending On Anniversary PeriodEndingOnAnniversary	P180D
CY2023	iroh	Number Of Shares Issued Per Unit NumberOfSharesIssuedPerUnit	1	shares
CY2023	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	35000	shares
CY2023	iroh	Effective Date EffectiveDate	P180D
CY2023	iroh	Threshold Period For Not To After Completion Of Initial Business Combination ThresholdPeriodForNotToAfterCompletionOfInitialBusinessCombination	P30D
CY2023	iroh	Warrants And Rights Outstanding Exercisable Term From Closing Of Initial Public Offering WarrantsAndRightsOutstandingExercisableTermFromClosingOfInitialPublicOffering	P12M
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1962	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1058	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	80501	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	16737	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	82463	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	17795	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	82463	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	17795	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-226	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-64668	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-16145	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	64668	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	16145	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-226	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	4306	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	4480	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	64668	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	16145	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.209	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.207	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.001	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.003	pure
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue		usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent		usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent		usd
CY2023Q4	us-gaap	Deferred Costs DeferredCosts		usd
CY2022Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent		usd
CY2022Q4	iroh	Overallotment Liability OverallotmentLiability		usd
CY2022Q4	iroh	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent		usd
CY2022Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding		shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest		usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest		usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense		usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2023	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther		usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense		usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities		usd
CY2022	iroh	Payments For Investment Of Cash Into Trust Account PaymentsForInvestmentOfCashIntoTrustAccount		usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
CY2022	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt		usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect		usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents		usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents		usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents		usd
CY2022	iroh	Remeasurement Of Common Stock Subject To Possible Redemption RemeasurementOfCommonStockSubjectToPossibleRedemption		usd
CY2022Q4	iroh	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable		usd
CY2022	iroh	Issuance Of Representative Shares IssuanceOfRepresentativeShares		usd
CY2022	iroh	Issuance Of Founder Shares IssuanceOfFounderShares		usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue		usd
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding		shares
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001901203

Files In Submission

Name	View Source	Status
0001213900-24-028817-index-headers.html	Edgar Link	pending
0001213900-24-028817-index.html	Edgar Link	pending
0001213900-24-028817.txt	Edgar Link	pending
0001213900-24-028817-xbrl.zip	Edgar Link	pending
ea0202557-10k_ironhorse.htm	Edgar Link	pending
ea020255701ex31-1_ironhorse.htm	Edgar Link	pending
ea020255701ex31-2_ironhorse.htm	Edgar Link	pending
ea020255701ex32-1_ironhorse.htm	Edgar Link	pending
ea020255701ex32-2_ironhorse.htm	Edgar Link	pending
ea020255701ex4-7_ironhorse.htm	Edgar Link	pending
ea020255701ex97-1_ironhorse.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
iroh-20231231.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
iroh-20231231_cal.xml	Edgar Link	unprocessable
iroh-20231231_def.xml	Edgar Link	unprocessable
iroh-20231231_lab.xml	Edgar Link	unprocessable
iroh-20231231_pre.xml	Edgar Link	unprocessable
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
ea0202557-10k_ironhorse_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IROH
Iron Horse Acquisitions Corp Stock $iroh

2024 Q1 Form 10-K Financial Statement

#000121390024028817 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IROH Iron Horse Acquisitions Corp Stock $iroh

2024 Q1 Form 10-K Financial Statement

#000121390024028817 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IROH
Iron Horse Acquisitions Corp Stock $iroh